Literature DB >> 17458552

The neuropathology and clinical phenotype of FTD with progranulin mutations.

Ian R A Mackenzie1.   

Abstract

Mutations in the progranulin gene (PGRN), on chromosome 17q21, have recently been identified as a major cause of familial frontotemporal dementia (FTD). These cases have a characteristic pattern of neuropathology that is a distinct subtype of frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U), with lentiform neuronal intranuclear inclusions being a consistent feature. There is no abnormal accumulation of PGRN protein in the brain and immunohistochemical and biochemical analysis indicates that the ubiquitinated pathological protein is TDP-43. In these families, FTD is inherited in an autosomal dominant fashion with high penetrance. The clinical phenotype is usually a combination of behavioural abnormality and language disturbance that is most often a form of primary progressive aphasia. Mild parkinsonism is common but motor neuron disease is notably rare. Marked variation in the disease course and clinical features are common, not only between families with different mutations, but also within individual families. This degree of clinical variability makes it difficult to predict which cases of familial FTD will turn out to have a PGRN mutation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458552     DOI: 10.1007/s00401-007-0223-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  54 in total

1.  Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.

Authors:  Naoya Aoki; Melissa E Murray; Kotaro Ogaki; Shinsuke Fujioka; Nicola J Rutherford; Rosa Rademakers; Owen A Ross; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2014-11-04       Impact factor: 17.088

2.  TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation.

Authors:  Maria Martinez-Lage; Laura Molina-Porcel; Dana Falcone; Leo McCluskey; Virginia M-Y Lee; Vivianna M Van Deerlin; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2012-08       Impact factor: 17.088

Review 3.  Biomarkers to identify the pathological basis for frontotemporal lobar degeneration.

Authors:  Murray Grossman
Journal:  J Mol Neurosci       Date:  2011-07-22       Impact factor: 3.444

Review 4.  Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

Review 5.  RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Authors:  Jeffrey W Hofmann; William W Seeley; Eric J Huang
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

6.  Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis.

Authors:  Yasuko Yamamoto; Masao Takemura; Ginette Serrero; Jun Hayashi; Binbin Yue; Aya Tsuboi; Hisako Kubo; Takashi Mitsuhashi; Kenji Mannami; Masao Sato; Hidetoshi Matsunami; Yushi Matuo; Kuniaki Saito
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 7.  The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Ian R A Mackenzie; Rosa Rademakers
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

8.  Progranulin is expressed within motor neurons and promotes neuronal cell survival.

Authors:  Cara L Ryan; David C Baranowski; Babykumari P Chitramuthu; Suneil Malik; Zhi Li; Mingju Cao; Sandra Minotti; Heather D Durham; Denis G Kay; Christopher A Shaw; Hugh P J Bennett; Andrew Bateman
Journal:  BMC Neurosci       Date:  2009-10-27       Impact factor: 3.288

9.  Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.

Authors:  Harro Seelaar; Kirsten Y Klijnsma; Inge de Koning; Aad van der Lugt; Wang Zheng Chiu; Asma Azmani; Annemieke J M Rozemuller; John C van Swieten
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

Review 10.  Molecular neuropathology of TDP-43 proteinopathies.

Authors:  Manuela Neumann
Journal:  Int J Mol Sci       Date:  2009-01-09       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.